Literature DB >> 10692044

T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus.

D C Douek1, D M Altmann.   

Abstract

Relatively little is known of the details of human leucocyte antigen (HLA) expression and thymocyte selection in human thymus. In both humans and mice major histocompatibility complex (MHC) molecules have been described which show a highly restricted thymic expression. Such patterns may offer clues about cellular interactions in thymic selection because transgenic mice with MHC expression targeted to specific thymic sites show altered T-cell receptor (TCR) repertoire selection. We have analysed human thymic HLA class II expression, relating the expression pattern to sites of thymocyte apoptosis. While HLA-DQ is poorly expressed by most peripheral antigen-presenting cells (APC), thymus stains strongly for HLA-DQ as well as for HLA-DR. HLA-DM is abundant in medulla but weakly expressed by cortical cells. Class II expression in Hassall's corpuscles (HC) is unusual in several respects: we have previously shown them to be encircled by HLA-DO+ epithelial cells and here further demonstrate that HC are negative for HLA-DR and HLA-DP, but often positive for HLA-DQ and HLA-DM. Transcriptional control of HLA class II products at this site is thus unlike cells that have previously been studied. Apoptotic thymocytes are restricted to the cortex and the corticomedullary junction. However, a minority of apoptotic cells are visible in the medulla, these being found in the HLA-DQ positive HC. The apoptotic thymocytes in HC can be CD4+ single positive (SP), CD8+ SP or CD4+CD8+ double-positive (DP). This study thus shows that the HC within human thymic medulla are noteworthy both for their unusual hierarchy of HLA class II expression and because they are the only medullary site of thymocyte apoptosis. We propose that HC are a site at which mature thymocytes receive activation/tolerization signals from peptides reprocessed from apoptotic cells. The differential HLA transcriptional control at this site may indicate that specific T-cell subpopulations are affected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692044      PMCID: PMC2327152          DOI: 10.1046/j.1365-2567.2000.00940.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

Review 1.  What is the basis for HLA-DQ associations with autoimmune disease?

Authors:  D M Altmann; D Sansom; S G Marsh
Journal:  Immunol Today       Date:  1991-08

Review 2.  HLA-DQ associations with autoimmune disease.

Authors:  D M Altmann
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

3.  The cytoarchitecture of the human thymus detected by monoclonal antibodies.

Authors:  D J Izon; R L Boyd
Journal:  Hum Immunol       Date:  1990-01       Impact factor: 2.850

4.  The phenotypic heterogeneity of mouse thymic stromal cells.

Authors:  D I Godfrey; D J Izon; C L Tucek; T J Wilson; R L Boyd
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

5.  B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene.

Authors:  S Y Tsang; M Nakanishi; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 6.  The thymic microenvironment.

Authors:  R L Boyd; C L Tucek; D I Godfrey; D J Izon; T J Wilson; N J Davidson; A G Bean; H M Ladyman; M A Ritter; P Hugo
Journal:  Immunol Today       Date:  1993-09

7.  Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.

Authors:  J Plum; M De Smedt; G Leclercq
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

8.  Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction.

Authors:  N C Moore; G Anderson; C A Smith; J J Owen; E J Jenkinson
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

9.  Activation events during thymic selection.

Authors:  A Bendelac; P Matzinger; R A Seder; W E Paul; R H Schwartz
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Two subsets of epithelial cells in the thymic medulla.

Authors:  C D Surh; E K Gao; H Kosaka; D Lo; C Ahn; D B Murphy; L Karlsson; P Peterson; J Sprent
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  10 in total

1.  Salmonid T cells assemble in the thymus, spleen and in novel interbranchial lymphoid tissue.

Authors:  Erling O Koppang; Uwe Fischer; Lindsey Moore; Michael A Tranulis; Johannes M Dijkstra; Bernd Köllner; Laila Aune; Emilio Jirillo; Ivar Hordvik
Journal:  J Anat       Date:  2010-09-29       Impact factor: 2.610

2.  Molecular and cellular characterization of European sea bass CD3ε+ T lymphocytes and their modulation by microalgal feed supplementation.

Authors:  Simona Picchietti; Francesco Buonocore; Laura Guerra; Maria Cristina Belardinelli; Tania De Wolf; Ana Couto; Anna Maria Fausto; Paolo Roberto Saraceni; Andrea Miccoli; Giuseppe Scapigliati
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 5.249

Review 3.  Expression of cell cycle and apoptosis regulators in thymus and thymic epithelial tumors.

Authors:  Alexandra Papoudou-Bai; Alexandra Barbouti; Vassiliki Galani; Kalliopi Stefanaki; Dimitra Rontogianni; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2015-03-21       Impact factor: 3.984

4.  HLA-DRB1 allele polymorphisms in genetic susceptibility to esophageal carcinoma.

Authors:  Jun Lin; Chang-Sheng Deng; Jie Sun; Xian-Gong Zheng; Xing Huang; Yan Zhou; Ping Xiong; Ya-Ping Wang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

5.  DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).

Authors:  Nathali Kaushansky; Daniel M Altmann; Chella S David; Hans Lassmann; Avraham Ben-Nun
Journal:  J Neuroinflammation       Date:  2012-02-08       Impact factor: 8.322

Review 6.  HLA-DO and Its Role in MHC Class II Antigen Presentation.

Authors:  Yuri O Poluektov; Aeryon Kim; Scheherazade Sadegh-Nasseri
Journal:  Front Immunol       Date:  2013-08-29       Impact factor: 7.561

Review 7.  The Repertoires of Peptides Presented by MHC-II in the Thymus and in Peripheral Tissue: A Clue for Autoimmunity?

Authors:  Javier A Collado; Carolina Guitart; M Teresa Ciudad; Iñaki Alvarez; Dolores Jaraquemada
Journal:  Front Immunol       Date:  2013-12-17       Impact factor: 7.561

8.  A Missing Switch in Peptide Exchange for MHC Class II Molecules.

Authors:  Christian Freund; Thomas Höfer
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance.

Authors:  Máté Manczinger; Lajos Kemény
Journal:  PeerJ       Date:  2018-07-03       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.